Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Pilot Study in Patients With Symptomatic Steroid-Naive Asthma

ClinicalTrials.gov ID: NCT00024544

Public ClinicalTrials.gov record NCT00024544. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 26, 2026, 5:23 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase I/II, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Pilot Study of SB 240683 in Patients With Symptomatic Steroid-Naive Asthma

Study identification

NCT ID
NCT00024544
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Facet Biotech
Industry
Enrollment
120 participants

Conditions and interventions

Conditions

Interventions

  • anti-IL-4 monoclonal antibody (pascolizumab) Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 31, 2001
Primary completion
Jan 31, 2003
Completion
Jan 31, 2003
Last update posted
Mar 6, 2012

2001 – 2003

United States locations

U.S. sites
18
U.S. states
12
U.S. cities
18
Facility City State ZIP Site status
Allergy Research Foundation Los Angeles California 90025
Southern California Research Mission Viejo California 92691
Clinical Trials of Orange Cnty., Inc. Orange California 92868
Allergy Associates Medical Group, Inc. San Diego California 92120
Allergy and Asthma Associates Santa Clara Valley Research Center San Jose California 95117
Bensch Research Associates Stockton California 95207
National Jewish Medical and Research Center Denver Colorado 80206
ICSL Clinical Studies Normal Illinois 61761
Respiratory Therapy and Pulmonary Clinical Research Brigham & Women's Hospital Boston Massachusetts 02115
New England Clinical Studies North Dartmouth Massachusetts 02747
Clinical Research Institute Minneapolis Minnesota 55402
The Clinical Research Center, LLC St Louis Missouri 63141
Center for Allergy, Asthma and Immunology, Creighton University Omaha Nebraska 68131
Princeton Center for Clinical Research Princeton New Jersey 08540
Allergy, Asthma, and Dermatology Research Center, LLC Lake Oswego Oregon 97035
Valley Clinical Research Center Easton Pennsylvania 18045
Clinical Trials North Houston Houston Texas 77090
University of Wisconsin Medical School Madison Wisconsin 53792

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00024544, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 6, 2012 · Synced Jun 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00024544 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →